Liposome Drug Delivery Market Demand, Supply, Growth Factors, Latest Rising Trend and Forecast to 2027


Karanshendage1089

Uploaded on Feb 23, 2023

Liposomes, a novel drug delivery system (NDDS), are bilayer vesicular structures used in delivering drugs or genetic material into a cell. The aim of NDDS is to deliver the drug at a rate directed by the needs of the body during the period of treatment. Read More:- https://www.theinsightpartners.com/reports/liposome-drug-delivery-market

Comments

                     

Liposome Drug Delivery Market Demand, Supply, Growth Factors, Latest Rising Trend and Forecast to 2027

Liposome Drug Delivery Market Global Analysis and Forecast to 2027 Published Date : Apr 2020 Email: [email protected] Email: [email protected] Report Studies  Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Others); Technology ( Stealth Liposome Technology, Non- PEGylated Liposome Technology, DepoFoam Liposome Technology, Lysolipid Thermally Sensitive Liposome (LTSL)); Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy) 2 Email: [email protected] $50,000 Liposome Drug Delivery $40,000 Market Value $30,000 CAGR of 8.8% $20,000 (2020 to 2027) $10,000 $0 20XX 20XX 20XX 20XX 20XX 3 Email: [email protected] Liposome Drug Delivery Market Overview  The liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027.  The liposome drug delivery market, by application, is segmented into fungal diseases, cancer therapy, pain management, viral vaccines, and photodynamic therapy. In 2019, the cancer therapy segment accounted for the largest market share of the global liposome drug delivery market. 4 Email: [email protected] Key Segment Market Segment By Type:-  Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Others)  Technology ( Stealth Liposome Technology, Non-PEGylated Liposome Technology, DepoFoam Liposome Technology, Lysolipid Thermally Sensitive Liposome (LTSL))  Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy) 5 Email: [email protected] Company Profiles  Takeda Pharmaceutical Company Limited  Novartis AG  Luye Pharma Group  Ipsen Pharma  CELSION, Inc.  Gilead Sciences, Inc.  Astellas Pharma, Inc.  Johnson & Johnson Services, Inc.  Acrotech Biopharma, Inc. 6 Download Sample Her e Email: [email protected] By Geography  North America (the US, Canada, and Mexico)  Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)  Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)  Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa)  South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7 THANK YOU! Phone : +1-646-491-9876 E-Mail : [email protected]